Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson, has announced that it will make its breakthrough new tuberculosis (TB) drug, Sirturo, available at a discount in 130 developing countries. As the first new antibiotic to be approved to treat
Read More...
Read the complete post at http://healthaffairs.org/blog/2014/06/13/roll-out-of-new-tb-drug-must-be-handled-with-care/?utm_source=rss&utm_medium=rss&utm_campaign=roll-out-of-new-tb-drug-must-be-handled-with-care
Posted
Jun 13 2014, 11:05 AM
by
Health Affairs Blog